Annamycin data

The Woodlands, Texas, company published animal results in Cancer Research, showing that annamycin both in suspension and in a liposomal version was more effective than doxorubicin, the standard anthracycline chemotherapeutic, in prolonging survival of mice implanted with various cancer lines, including reticulosarcoma tumors, melanoma, and lung cancer.

For example, with the lung cancer model, more than half of the animals treated with annamycin (on day 18) were still alive at 90 days after receiving implants of the cancer cells, whereas all those given doxorubicin had died. ...